Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
about
The past, present and future of immunotherapy against tumorTherapeutic cancer vaccines and combination immunotherapies involving vaccinationp38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression.Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitro.DNA methylation dynamics during ex vivo differentiation and maturation of human dendritic cells.Circulating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.Dendritic-cell-based therapeutic cancer vaccinesEfficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.Interleukin-10 reorganizes the cytoskeleton of mature dendritic cells leading to their impaired biophysical properties and motilitiesA novel personalized vaccine approach in combination with targeted therapy in advanced renal cell carcinoma.Self-adjuvanting lipoimmunogens for therapeutic HPV vaccine development: potential clinical impact.Could mycobacterial Hsp70-containing fusion protein lead the way to an affordable therapeutic cancer vaccine?Personalized immunotherapy ( AGS-003 ) when combined with sunitinib for the treatment of metastatic renal cell carcinoma.Brain Tumor Immunotherapy: What have We Learned so Far?Dendritic cell based vaccination strategy: an evolving paradigm.Rationale for stimulator of interferon genes-targeted cancer immunotherapy.Mannan Derivatives Instruct Dendritic Cells to Induce Th1/Th2 Cells Polarization via Differential Mitogen-Activated Protein Kinase Activation.Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.Tumor Immuno-Environment in Cancer Progression and Therapy.Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.Utilizing the nanosecond pulse technique to improve antigen intracellular delivery and presentation to treat tongue squamous cell carcinoma.Automated, Miniaturized, and Integrated Quality Control-on-Chip (QC-on-a-Chip) for Cell-Based Cancer Therapy Applications
P2860
Q26799896-1A727C8C-1F76-4867-BFA0-7263C99A8D5AQ28397609-E2F50D1E-3456-4E85-91AA-FC2E79F53BA0Q30422500-4D5DB670-F877-4C5F-8925-9784ED66A730Q34028415-DBF8AB7C-E1C0-45BE-B383-30DAAB473BC5Q34090282-2D814615-2B48-4358-BC2A-52D8DD20E4DDQ34259974-31530266-5103-4F54-A3F4-7292552D747FQ34360094-7320F90C-B63A-4384-B064-3F72B20C0E0AQ35224721-DBBDC55D-1B8A-4C16-BABC-EACFEC8EA041Q36289748-48180075-CB5A-4D17-8348-21031DBEC22FQ38172644-8B1A6B28-3AD8-4D1C-9B00-E99240BF00E9Q38279548-7D4CBE59-6D12-40C0-9B76-00534338BC2FQ38286381-B8ECBC6F-F661-491C-A346-13CE77EF8981Q38540687-002BD583-5443-4B33-A397-999E3D05B741Q38542113-01363860-AF4A-47BF-9206-5BA87ABBA817Q38691953-7171320E-73B3-4D36-9F0B-CAD1ABE3C0C9Q39144454-798547D6-A12C-48BB-AEA9-CC359D78904EQ41019947-172B11AF-F0F9-4D17-BDE1-BEAEB5168CF9Q42244141-0967DF0A-6794-48C2-B634-E9A3FAF2C070Q49592937-0B87A529-BE28-49AD-A143-968E694B71F0Q52691583-0FAE1492-5C8B-4B4E-AA18-6311E67C5825Q55004711-0CD29D99-3B25-4F93-A5F0-49D232959177Q57901322-41D135B1-303D-4F35-A016-011F5B1134EE
P2860
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@ast
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@en
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@nl
type
label
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@ast
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@en
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@nl
prefLabel
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@ast
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@en
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies.
@nl
P356
P1476
Dendritic cells in cancer immunotherapy: vaccines and combination immunotherapies
@en
P2093
Julie Urban
Pawel Kalinski
P304
P356
10.1586/ERV.13.22
P577
2013-03-01T00:00:00Z